Achmea Investment Management B.V. Vertex Pharmaceuticals Inc Transaction History
Achmea Investment Management B.V.
- $6.06 Billion
- Q3 2024
A detailed history of Achmea Investment Management B.V. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Achmea Investment Management B.V. holds 15,934 shares of VRTX stock, worth $6.72 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
15,934
Previous 36,590
56.45%
Holding current value
$6.72 Million
Previous $17.2 Million
56.79%
% of portfolio
0.12%
Previous 0.31%
Shares
23 transactions
Others Institutions Holding VRTX
# of Institutions
1,718Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11.3 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.77 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.99 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.99 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.8 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $108B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...